These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

84 related items for PubMed ID: 10599697

  • 1. Somatostatin infusion withdrawal: studies in normal children and in children with growth hormone deficiency.
    Cappa M, Rigamonti AE, Bizzarri C, Porzio O, Civolani P, Cella SG, Loche S, Müller EE.
    J Clin Endocrinol Metab; 1999 Dec; 84(12):4426-30. PubMed ID: 10599697
    [Abstract] [Full Text] [Related]

  • 2. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity.
    Alvarez P, Isidro L, Leal-Cerro A, Casanueva FF, Dieguez C, Cordido F.
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):487-92. PubMed ID: 11966741
    [Abstract] [Full Text] [Related]

  • 3. Somatostatin infusion withdrawal in the diagnosis of childhood growth hormone deficiency.
    Bosnak M, Dikici B, Haspolat K, Dogru O, Ozkan I, Ece A.
    Pediatr Int; 2003 Oct; 45(5):538-42. PubMed ID: 14521528
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone (GH) rebound rise following somatostatin infusion withdrawal: studies in dogs with the use of GH-releasing hormone and a GH-releasing peptide.
    Rigamonti AE, Cavallera G, Bonomo S, Deghenghi R, Locatelli V, Cella SG, Müller EE.
    Eur J Endocrinol; 2001 Nov; 145(5):635-44. PubMed ID: 11720883
    [Abstract] [Full Text] [Related]

  • 5. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB, Root AW, Shulman DI.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):968-73. PubMed ID: 3018032
    [Abstract] [Full Text] [Related]

  • 6. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.
    Leal-Cerro A, Soto A, Martínez MA, Alvarez P, Isidro L, Casanueva FF, Dieguez C, Cordido F.
    Clin Endocrinol (Oxf); 2002 Dec; 57(6):745-9. PubMed ID: 12460324
    [Abstract] [Full Text] [Related]

  • 7. Combined growth hormone-releasing hormone and growth hormone-releasing peptide-6 test for the evaluation of growth hormone secretion in children with growth hormone deficiency and growth hormone neurosecretory dysfunction.
    Spiliotis BE, Papadimitriou DT, Alexandrides TK, Karystianos C, Nikiforidis G, Vassilakos P, Beratis NG, Casanueva FF.
    Horm Res; 2008 Dec; 70(4):215-23. PubMed ID: 18772594
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M, Salati B, Bianchi S, Rallo M, Tinelli C, Autelli M, Aimaretti G, Ghigo E.
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnosis of growth hormone (GH) deficiency in adults with hypothalamic-pituitary disorders: comparison of test results using pyridostigmine plus GH-releasing hormone (GHRH), clonidine plus GHRH, and insulin-induced hypoglycemia as GH secretagogues.
    Hoeck HC, Vestergaard P, Jakobsen PE, Falhof J, Laurberg P.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1467-72. PubMed ID: 10770183
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Estrogen priming effect on growth hormone (GH) provocative test: a useful tool for the diagnosis of GH deficiency.
    Martínez AS, Domené HM, Ropelato MG, Jasper HG, Pennisi PA, Escobar ME, Heinrich JJ.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4168-72. PubMed ID: 11095449
    [Abstract] [Full Text] [Related]

  • 17. The growth hormone response to hexarelin in patients with different hypothalamic-pituitary abnormalities.
    Maghnie M, Spica-Russotto V, Cappa M, Autelli M, Tinelli C, Civolani P, Deghenghi R, Severi F, Loche S.
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3886-9. PubMed ID: 9814463
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone (GH) provocative testing frequently does not reflect endogenous GH secretion.
    Bercu BB, Shulman D, Root AW, Spiliotis BE.
    J Clin Endocrinol Metab; 1986 Sep; 63(3):709-16. PubMed ID: 3525601
    [Abstract] [Full Text] [Related]

  • 19. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M, Guyda H, Van Vliet G, Tannenbaum GS.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [Abstract] [Full Text] [Related]

  • 20. Growth hormone (GH) response to GH-releasing hormone in children with subnormal integrated concentrations of GH.
    Chalew SA, Armour KM, Levin PA, Thorner MO, Kowarski AA.
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1110-5. PubMed ID: 3084533
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.